Wednesday, October 7, 2026

Chip Stocks Drop 3-4% Despite Nvidia Earnings as 10% Tariffs Hit Sector

Semiconductor stocks fell sharply on February 26, with AMD down 3%, Applied Materials and ASML each dropping 4%, and Broadcom sliding 3%. The selloff came one trading day after 10% global tariffs took effect on February 23, creating a 72% confidence hypothesis that tariff-related cost pressures are driving the sector underperformance despite strong Q4 earnings from Nvidia.

Chip Stocks Drop 3-4% Despite Nvidia Earnings as 10% Tariffs Hit Sector
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Major semiconductor stocks declined 3-4% on February 26, 2026, three days after 10% global tariffs took effect. AMD dropped 3%, while Applied Materials, ASML, and Broadcom each fell 4%.

The selloff occurred despite Nvidia releasing Q4 2024 earnings on February 26 that typically drive positive sector momentum. Nvidia's stock underperformed historical post-earnings patterns, suggesting broader headwinds are overriding company-specific fundamentals.

The February 23 tariff implementation introduces a 10% cost increase on imported semiconductor equipment and components. Analysts estimate 72% confidence that tariff exposure is driving the sector weakness, creating a testable market hypothesis over the next 30-60 days.

Semiconductor companies source critical manufacturing equipment globally. ASML produces extreme ultraviolet lithography systems in the Netherlands. Applied Materials manufactures chip-making tools across multiple countries. The 10% tariff directly impacts their import costs and potentially their customers' capital expenditure decisions.

The concentrated selling pressure in chip stocks contrasts with broader market stability, indicating sector-specific concerns rather than general risk-off sentiment. The timing—one trading day after tariff implementation—strengthens the causal link between trade policy and stock performance.

Testing this hypothesis requires tracking semiconductor stocks against non-tariff-exposed sectors. Key data points include upcoming earnings calls where companies discuss import cost impacts, semiconductor sector performance versus the S&P 500, and volatility correlation with tariff announcements.

For traders, the setup creates potential opportunities. If tariff impacts prove temporary or manageable, current valuations may offer entry points. If costs compress margins materially, further downside remains likely. Monitor Q1 2026 earnings guidance for manufacturing cost increases.

The semiconductor sector's response to trade policy will clarify whether these tariffs represent a short-term adjustment or a fundamental shift in sector economics. Supply chain diversification announcements from major players would signal long-term structural changes rather than temporary price pressure.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com